Researchers at the University of Birmingham, UK, are collaborating with scientists from China’s Guangzhou Institutes of Biomedicine and Health (GIBH) to develop new medicines for treating global epidemics. The university’s team has discovered multiple […]
Biogen has signed an exclusive option agreement to buy Japan-based biotechnology company TMS’ TMS-007 drug candidate being developed for the treatment of acute ischemic stroke (AIS). The agreement also covers TMS-007’s backup compounds and […]
Genentech has formed a multi-year strategic alliance with Wellcome Sanger Institute’s Microbiotica to address inflammatory bowel disease (IBD). Focused on microbiomes, the collaboration will see discovery, development and commercialisation of biomarkers, targets and drugs […]
The US Food and Drug Administration (FDA) has filed a complaint against pharmaceutical company Innovative BioDefense for producing drugs not approved by the regulator. The FDA’s complaint sought to prohibit Innovative BioDefense and its […]
Immuno-oncology startup Oncologie has formally launched its operations in Boston and Shanghai following $16.5 million in seed funding, with the goal of delivering new cancer therapies in the U.S. and Chinese markets simultaneously. Founded […]